Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.2 was added, and the Notice about government funding and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoChange DetectedAdded a site-wide notice about government funding and NIH Clinical Center operating status. Updated the history page to Revision: v3.4.1 and removed the v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check16 days agoChange DetectedRecord History page now includes a glossary toggle and color-coded highlights to distinguish additions and deletions, along with updated revision notes (v3.4.0). Capitalization for 'No FEAR Act Data' has been standardized.SummaryDifference0.6%

- Check31 days agoChange DetectedThe page history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3, reflecting a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedFooter metadata updated to Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check80 days agoChange DetectedA new version (v3.3.2) was added on 2025-11-21 with an updated Study Status. The previous revision (v3.2.0) was removed on 2025-08-28.SummaryDifference0.3%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.